window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Women in Pharma

Women in PharmaDebbie2026-02-23T12:09:55+00:00
  • Clinical Trials,Healthcare leadership,Women in Pharma

    Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials

    From hospital haematology to leading early stage clinical trials, Margaret [...]

    read more
  • Biomanufacturing,CDMOs & Manufacturing,Events and Conferences,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    read more
  • Biotech,Clinical Trials,FDA,Hematology,Rare Diseases,Regulatory Affairs

    Hemab Therapeutics wins FDA breakthrough therapy status for sutacimig in Glanzmann thrombasthenia

      The FDA has granted breakthrough therapy designation to Hemab [...]

    read more
  • Uncategorised

    Outpost Bio raises $3.5M pre-seed to build AI models of human microbiology

    Outpost Bio has raised $3.5m in a pre-seed round to [...]

    read more
  • Artificial Intelligence,Oncology

    Insilico nominates pan-KRAS candidate ISM6166 after tumour regression in preclinical studies

    Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

    read more
  • Clinical studies,Dermatology,Medical devices

    Laser therapy reduces bacterial load in burn wounds, study shows

    A single photobiomodulation session reduced bacterial load in acute burn [...]

    read more
  • Clinical Trials,Infectious Diseases,Vaccines

    Ethris part of EU consortium to advance novel pandemic influenza vaccine

    Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

    read more
  • Cardiovascular diseases,Clinical Trials,Rare Diseases

    Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

    As Rare Disease Day 2026 shines a spotlight on patients [...]

    read more
  • Rare Diseases

    Rare Disease Day 2026: Er-Kim pushes to close access gap in underserved markets

    As Rare Disease Day 2026 highlights the challenges faced by [...]

    read more
  • Biotech,Cell & Gene Therapy,Drug Development,Oncology,Partnerships & Funding

    Molecular Partners signs development agreement with Eckert & Ziegler for targeted alpha Radio-DARPin therapeutics

    Molecular Partners AG, a clinical-stage biotech developing DARPin-based therapeutics, announced [...]

    read more
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen
    Categories: Clinical Development, Infectious Diseases, Patient Centricity, Precision medicine
  • SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics
    Categories: Diagnostics, Oncology, Partnerships & Funding
  • Young adults in US, UK and Australia hit hardest by global mental health decline
    Categories: Clinical studies, Digital Health, Global health, Mental health, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top